Kirkwood, J.; Dummer, R.; Hauschild, A.; Santinami, M.; Atkinson, V.; Sileni, V.; Larkin, J.; Nyakas, M.; Haydon, A.; Dutriaux, C.; Schachter, J.; Robert, C.; Mortier, L.; Banerjee, H.; Haas, T.; Tan, M.; Lau, M.; Schadendorf, D.; Long, G.; Mandala, M. Restricted Mean Survival Time and Cure-Rate Modeling in Estimating Relapse-Free Survival Benefit With Adjuvant Dabrafenib + Trametinib Treatment in Melanoma. J of Skin 2021, 5, s2.